Back to CI Champlain Investment Partners, LLC

WSTWST

Showing 8 of 26 quarters

Position history for CIChamplain Investment Partners, LLC's holdings in WEST PHARMACEUTICAL SVSC INC

No. Champlain Investment Partners exited its WST (West Pharmaceutical SVSC) position in Q2 2026. Its Q1 2026 13F listed 205,979 shares worth $51.6M. Champlain Investment Partners already held WST in its Q1 2019 13F, the earliest on record, and held it in 24 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$133.3M

Total Shares Change

-444,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$358.77
0
2026-Q1
Decreased
205,979
-56.7%
$51.6M0.7%$250.29
0
2025-Q4
Increased
475,355
+3.6%
$130.8M1.3%$274.50
49
2025-Q3
Increased
458,920
+2.5%
$120.4M0.9%$261.51
43
2025-Q2
Decreased
447,675
-5.0%
$98M0.7%$217.94
0
2025-Q1
Increased
471,175
+6.0%
$105.5M0.8%$222.78
45
2024-Q4
Increased
444,670
+0.1%
$145.7M0.9%$325.74
43
2024-Q3
Increased
444,000
+29.7%
$133.3M0.8%$298.30
54

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used